GENERAL — Sales to customers (Note 9)
Johnson & Johnson GENERAL — Sales to customers (Note 9) decreased by 5.4% to $1.39B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.9%, from $1.32B to $1.39B. Over 4 years (FY 2021 to FY 2025), GENERAL — Sales to customers (Note 9) shows relatively stable performance with a 1.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market demand or successful commercial execution within this specific business area, while a decrease may signal market saturation, competitive pressure, or product lifecycle maturity.
Detailed definition
This metric represents the total revenue generated from the sale of products or services within the specific business se...
Peer comparison
Comparable to segment-specific net revenue or product line sales reported by diversified healthcare or consumer goods conglomerates.
jnj_segment_general_sales_to_customers_note_9Historical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.35B | $1.26B | $1.32B | $1.29B | $1.29B | $1.26B | $1.28B | $1.32B | $1.37B | $1.31B | $1.36B | $1.33B | $1.35B | $1.33B | $1.36B | $1.32B | $1.39B | $1.38B | $1.47B | $1.39B |
| QoQ Change | — | -6.9% | +4.8% | -2.5% | +0.5% | -2.3% | +0.9% | +3.2% | +4.3% | -4.2% | +3.8% | -2.5% | +1.2% | -1.6% | +2.4% | -2.5% | +5.1% | -0.9% | +6.5% | -5.4% |
| YoY Change | — | — | — | — | -4.4% | +0.2% | -3.5% | +2.2% | +6.0% | +4.0% | +7.0% | +1.1% | -1.9% | +0.8% | -0.5% | -0.5% | +3.3% | +4.0% | +8.2% | +4.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's general — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported general — sales to customers (note 9) of $1.39B in Q1 2026.
- How has Johnson & Johnson's general — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's general — sales to customers (note 9) increased by 4.9% year-over-year, from $1.32B to $1.39B.
- What is the long-term trend for Johnson & Johnson's general — sales to customers (note 9)?
- Over 4 years (2021 to 2025), Johnson & Johnson's general — sales to customers (note 9) has grown at a 1.7% compound annual growth rate (CAGR), from $5.19B to $5.56B.
- What does general — sales to customers (note 9) mean?
- The total revenue earned from the General product line or business segment.